Stockscreener 앱 받기
7.34
0.41%
-0.03
Vir Biotechnology Inc (VIR) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
235.83%
56.38
|
16.79 | 2.639 | 3.797 | 62.96 |
| Cost Of Revenue |
92.61%
0.059
|
0.798 | 0.038 | 0.022 | 1.907 |
| Gross Profit |
252.22%
56.32
|
15.99 | 2.601 | 3.775 | 61.05 |
Operating Expenses
|
12.00%
136.40
|
155.00 | 189.33 | 218.96 | 204.42 |
| Benefits Costs and Expenses |
11.75%
121.38
|
137.54 | 169.26 | 201.42 | 206.15 |
| Costs And Expenses |
12.42%
136.46
|
155.80 | 189.37 | 218.98 | 206.33 |
| Operating Income/Loss |
42.39%
-80.08
|
-139.02 | -186.73 | -215.19 | -143.37 |
| Nonoperating Income/Loss |
17.41%
15.08
|
18.26 | 20.11 | 17.56 | 0.183 |
| Income/Loss From Continuing Operations Before Tax |
46.17%
-65.00
|
-120.76 | -166.63 | -197.62 | -143.19 |
| Income Tax Expense/Benefit |
105.77%
0.276
|
-4.784 | -3.213 | -2.848 | -2.232 |
| Income/Loss From Continuing Operations After Tax |
43.71%
-65.28
|
-115.97 | -163.41 | -194.78 | -140.96 |
|
Net Income/Loss
|
43.71%
-65.28
|
-115.97 | -163.41 | -194.78 | -140.96 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | -0.056 |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
83,901%
135.28
|
0.161 | 134.29 | 134.06 | 133.55 |
| Diluted Average Shares |
83,901%
135.28
|
0.161 | 134.29 | 134.06 | 133.55 |
| Basic Earnings Per Share |
44.19%
-0.48
|
-0.86 | -1.22 | -1.45 | -1.06 |
| Diluted Earnings Per Share |
44.19%
-0.48
|
-0.86 | -1.22 | -1.45 | -1.06 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | -0.056 |
2.88%
2.65%
자본화:
|
볼륨(24시간):